Financing ·
TELA Bio secures limited consent from Perceptive Credit Holdings V to waive minimum Revenue covenant for two fiscal quarters
TELATELA Bio, Inc.
TELA Bio, Inc. entered into a Limited Consent to Credit Agreement with Perceptive Credit Holdings V, LP on September 28, 2026. The consenting lenders agreed that the minimum Revenue covenant under the existing Credit Agreement dated November 13, 2025, shall not be tested for fiscal quarters ending approximately September 30, 2026, and December 31, 2026. This waiver allows the company to bypass specific financial performance requirements during these periods. TELA Bio operates in the medical device industry, specializing in wound care solutions.